Gadolinium-based contrast agents (GBCAs) are widely used in magnetic resonance imaging (MRI) to enhance lesion detection and characterisation, particularly in the field of neuro-oncology. Nevertheless, concerns regarding gadolinium retention and accumulation in brain and body tissues, most notably for diseases that require close monitoring and frequent GBCA injection, have led to the need for strategies to reduce dosage. In this study, a deep learning framework is proposed for the virtual contrast enhancement of full-dose post-contrast T1-weighted MRI images from corresponding low-dose acquisitions. The contribution of the presented model is its utilisation of longitudinal information, which is achieved by incorporating a prior full-dose MRI examination from the same patient. A comparative evaluation against a non-longitudinal single session model demonstrated that the longitudinal approach significantly improves image quality across multiple reconstruction metrics. Furthermore, experiments with varying simulated contrast doses confirmed the robustness of the proposed method. These results emphasize the potential of integrating prior imaging history into deep learning-based virtual contrast enhancement pipelines to reduce GBCA usage without compromising diagnostic utility, thus paving the way for safer, more sustainable longitudinal monitoring in clinical MRI practice.
Fayolle et al. (Wed,) studied this question.